Work

N0234: Phase II study of erlotinib (OSI-774) plus gemcitabine as first-or second-line therapy for metastatic breast cancer (MBC)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.644

Authors: D. L. Graham, D. W. Hillman, T. J. Hobday, S. R. Rousey, S. G. Nair, G. S. Soori, T. M. Sabagh, E. A. Perez

Institutions: Mayo Clinic, Lehigh Valley Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589727738

Cites:

Cited by: 20

Related to: 10